MYLAN ApS
APSDissolvedCVR 28107013Borupvang 1, 2750 BallerupWholesale of pharmaceutical and medical goods· NACE 4646Est. 2004 · 22 years old— employees
Loading company…
Overview
MYLAN ApS is a Danish APS based in Ballerup, operating in the Wholesale of pharmaceutical and medical goods sector. Incorporated in 2004, the company reported a gross profit of DKK 3.6k in its latest annual filing.
Gross profit 2024
3.6K DKK
+49% vs 2023
EBITDA margin (of gross profit)
100.0 %
+49% vs 2023
Net profit 2024
3.1K DKK
+61% vs 2023
Key ratios
See full ratios →Solidity ratioEquity ÷ Total assets × 100
76.7 %
Very strongAmong the 20% highest rated companies in the industry
20202024
Liquidity ratioCurrent assets ÷ Short-term debt
4.3×
Very strongAmong the 20% highest rated companies in the industry
20202024
Return on assets (ROA)Net profit ÷ Total assets × 100
1.2 %
AverageAround the average of companies in the same industry
20202024
EBITDA — year on year
DKKKey figures
Annual report 2024| Gross profit | 3.6K DKK | +49% |
| EBITDA | 3.6K DKK | +49% |
| Net profit | 3.1K DKK | +61% |
| Total assets | 259.4K DKK | +1% |
| Equity | 199K DKK | +2% |
| Employees | — | — |
Company information
Legal name
MYLAN ApS
CVR number
28107013
Legal form
Anpartsselskab
NACE code
Founded
10 September 2004 · 22 years
Share capital
DKK 125,000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør, af et medlem af bestyrelsen eller af den samlede bestyrelse.
Address
Borupvang 1, 2750 Ballerup
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Financial development
In its most recent annual report (2024), MYLAN ApS reported a gross profit of DKK 3.6k, an increase of 49% on the year before. The figures on this page draw on 5 annual filings covering 2020 to 2024. The bottom line showed a net profit of DKK 3.1k, and the EBITDA margin stood at 100%.
At the end of 2024, equity financed 76.7% of the balance sheet, and current assets covered short-term debt 4.3 times.
Financials
Gross profit
DKKEBITDA
DKKIncome statement
DKK thousands| Item | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Gross profit | 4 | 2 | 2 | 5 | 5 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 4 | 2 | 2 | 5 | 5 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | 4 | 2 | 2 | 5 | 5 |
| Net financials | 0 | 0 | -2 | -3 | -3 |
| Profit before tax | 4 | 3 | 0 | 3 | 3 |
| Tax | 1 | 1 | 0 | 1 | 1 |
| Net profit | 3 | 2 | 0 | 2 | 2 |
Balance sheet
DKK thousands| Item | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total assets | 259 | 257 | 341 | 378 | 350 |
| Equity | 199 | 196 | 194 | 194 | 192 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 60 | 61 | 147 | 185 | 158 |
| Total debt | 60 | 61 | 147 | 185 | 158 |
Financial ratios
5-year trendEBITDA margin (of gross profit)
100.0 %
20202024
Equity ratio
76.7 %
Very strongAmong the 20% highest rated companies in the industry
20202024
Return on equity
1.6 %
WeakAmong the 40% lowest rated companies in the industry
20202024
Net profit margin (of gross profit)
86.4 %
20202024
Asset turnover (of gross profit)
0.01×
20202024
Debt / equity
0.30×
StrongAmong the 30% highest rated companies in the industry
20202024
Sector performance
21 of 28 ratios graded28 financial ratios from the latest filing, each graded against companies in the same industry.
Profitability
Return on equity (ROE)Weak
Among the 40% lowest rated companies in the industry
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Return on assets (ROA)Average
Around the average of companies in the same industry
Net profit as a percentage of total assets — the return generated on the capital employed.
Return on net assets (RONA)Weak
Among the 40% lowest rated companies in the industry
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Basic earning power (BEP)Average
Around the average of companies in the same industry
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Gross marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
Operating marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
Net profit marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Capacity ratioNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
Liquidity
Current ratioVery strong
Among the 20% highest rated companies in the industry
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Quick ratioVery strong
Among the 20% highest rated companies in the industry
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash ratioStrong
Among the 30% highest rated companies in the industry
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Current assets to equityStrong
Among the 40% highest rated companies in the industry
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Fixed assets to long-term capitalVery strong
Among the 10% highest rated companies in the industry
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Cash conversion ratioAverage
Around the average of companies in the same industry
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Debt & solvency
Solidity ratioVery strong
Among the 20% highest rated companies in the industry
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Debt ratioVery strong
Among the 20% highest rated companies in the industry
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Debt to equityStrong
Among the 30% highest rated companies in the industry
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Liabilities to equityStrong
Among the 30% highest rated companies in the industry
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Income to debtAverage
Around the average of companies in the same industry
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA to debtAverage
Around the average of companies in the same industry
EBITDA relative to debt — how much operating earnings are available to service the debt.
Interest rate on debtVery strong
Among the 10% highest rated companies in the industry
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
Interest marginAverage
Around the average of companies in the same industry
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Interest coverageNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The ability to pay the interest on the company's debt out of its earnings.
Efficiency & development
Equity to contributed capitalWeak
Among the 40% lowest rated companies in the industry
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
One-year change in equityAverage
Around the average of companies in the same industry
The size of this year's increase or decrease in the company's equity.
One-year change in debtAverage
Around the average of companies in the same industry
The size of this year's increase or decrease in the company's debt.
Asset turnoverNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Revenue relative to total assets — the ability to generate revenue from the asset base.
Inventory turnoverNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
Annual reports & filings
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
People & ownership
Management
Actively employed in the business| Name | Role | Member since |
|---|
Former (8)
JU Management | Management | 2016 – 2026 |
LH Chief Executive Officer | Chief Executive Officer | 2026 – 2026 |
GB Management | Management | 2008 – 2011 |
CE Management | Management | 2004 – 2011 |
OJ Chief Executive Officer | Chief Executive Officer | 2004 – 2008 |
OF Chief Executive Officer | Chief Executive Officer | 2016 – 2016 |
EA Chief Executive Officer | Chief Executive Officer | 2011 – 2016 |
OG Chief Executive Officer | Chief Executive Officer | 2004 – 2004 |
Board of directors
Non-executive oversight| Name | Role | Member since |
|---|
Former (13)
JU Chairman | Chairman | 2016 – 2026 |
LH Chairman | Chairman | 2026 – 2026 |
JB Board of Directors | Board of Directors | 2016 – 2017 |
GJ Board of Directors | Board of Directors | 2017 – 2018 |
AN Board of Directors | Board of Directors | 2023 – 2026 |
JJ Board of Directors | Board of Directors | 2018 – 2021 |
JB Board of Directors | Board of Directors | 2016 – 2016 |
AM Board of Directors | Board of Directors | 2017 – 2018 |
BB Board of Directors | Board of Directors | 2023 – 2026 |
KG Board of Directors | Board of Directors | 2018 – 2023 |
JO Board of Directors | Board of Directors | 2016 – 2017 |
LR Board of Directors | Board of Directors | 2021 – 2023 |
OF Chairman | Chairman | 2016 – 2016 |
Shareholders
Active legal owners| Shareholder | Type | Ownership | Votes | Registered |
|---|---|---|---|---|
Scandinavian Pharmaceuticals-Generics AB | Company | 100% | 100% | 2004 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Related companies
Company hierarchy
Scandinavian Pharmaceuticals-Generics AB100%
MYLAN ApS (this company)Board network connections
Board members of MYLAN ApS also hold positions in 8 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gitte Jürgens | Board of Directors | 4 companies |
| Lars Henrik Andreas Rejnus | Chief Executive Officer | 1 company |
| Olaf Georg Koktvedgaard | Chief Executive Officer | 1 company |
| Arun Narayan | Board of Directors | 1 company |
| Bente Brumoen | Board of Directors | 1 company |
Frequently asked questions
What is the CVR number of MYLAN ApS?
MYLAN ApS is registered with CVR / Virk under CVR 28107013.
What is the gross profit of MYLAN ApS?
MYLAN ApS reported a gross profit of DKK 3.6k in 2024.
Where is MYLAN ApS headquartered?
MYLAN ApS's registered address is Borupvang 1.